Eli Lilly and Comp. (LLY) stock forecast for 2024. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Eli Lilly and Comp. (LLY) stock forecast for 2024

Updated: April 18, 2024 (08:38)

Sector: Healthcare

The share price of Eli Lilly and Company (LLY) now

What analysts predict: $826.53
52-week High/Low: $800.78 / $366.69

50/200 Day Moving Average: $760.53 / $611.38

This figure corresponds to the Average Price over the previous 50/200 days. For Eli Lilly and Comp. stocks, the 50-day moving average is the resistance level today.

For Eli Lilly and Comp. stocks, the 200-day moving average is the resistance level today.

Are you interested in Eli Lilly and Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Eli Lilly and Comp. stock price in 2024. How much will one Eli Lilly and Comp. share be worth in 2024? Is it worth taking profit / loss on LLY stock now or waiting? What are analysts' forecasts for Eli Lilly and Comp. stock?

We forecast Eli Lilly and Comp. stock performance using neural networks based on historical data on LLY stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Eli Lilly and Company stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Eli Lilly and Comp. analysts is $826.53. Today 200 Day Moving Average is the support level (611.38 $). 50 Day Moving Average is the support level (760.53 $).




Historical and forecast chart of Eli Lilly and Company stock

The chart below shows the historical price of Eli Lilly and Comp. stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the LLY stock price can be found in the table below.


Sell or Buy Eli Lilly and Comp. (LLY) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the LLY stock market. Experts share their opinions on what to expect.

Eli Lilly and Company is an American pharmaceutical company. It was founded in 1876 in Indianapolis, Indiana, where its headquarters are still located. It is known as the first company to start the industrial production of insulin (in 1923). The company operates in two areas: medicines for humans and veterinary medicines (a division of Elanco). The company’s products are sold in 120 countries.

www.lilly.com

Eli Lilly and Comp. (LLY) Forecast for 2024

Month Target Pes. Opt. Vol., %
May 816.16 783.27 863.91 9.33 %
Jun 852.24 787.98 940.87 16.25 %
Jul 896.55 841.77 940.84 10.53 %
Aug 933.85 861.01 1 000.62 13.95 %
Sep 812.45 758.58 855.75 11.35 %
Oct 829.35 806.71 913.44 11.69 %
Nov 885.41 808.29 921.09 12.25 %
Dec 833.62 762.09 868.29 12.23 %

Eli Lilly and Comp. information and performance

Eli Lilly and Comp. Address

LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US

Market Capitalization: 713 806 512 000 $

Market capitalization of the Eli Lilly and Company is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of LLY shares in the company outstanding by the market price of one share.

EBITDA: 12 314 600 000 $

EBITDA of Eli Lilly and Comp. is earnings before interest, income tax and depreciation of assets.

PE Ratio: 128.31

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.431

Price/earnings to growth

DPS: 4.52

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.007

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 5.82

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.13
Quarterly Revenue Growth YOY: 0.281
Trailing PE: 128.31

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 60.24

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 21.6

Enterprise Value (EV) /Revenue

EV To EBITDA: 86.01

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 950766000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Eli Lilly and Comp. price target for 2024 by month


Target values for the price of one Eli Lilly and Comp. share for May 2024.

The weighted average target price per Eli Lilly and Comp. share in May 2024 is: 816.16.
In May, the Positive dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 9.334% volatility is expected.
Pessimistic target level: 783.27
Optimistic target level: 863.91

Target values for the price of one Eli Lilly and Comp. share for Jun 2024.

The weighted average target price per Eli Lilly and Comp. share in Jun 2024 is: 852.24.
In Jun, the Positive dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 16.250% volatility is expected.
Pessimistic target level: 787.98
Optimistic target level: 940.87

Target values for the price of one Eli Lilly and Comp. share for Jul 2024.

The weighted average target price per Eli Lilly and Comp. share in Jul 2024 is: 896.55.
In Jul, the Positive dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 10.530% volatility is expected.
Pessimistic target level: 841.77
Optimistic target level: 940.84

Target values for the price of one Eli Lilly and Comp. share for Aug 2024.

The weighted average target price per Eli Lilly and Comp. share in Aug 2024 is: 933.85.
In Aug, the Positive dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 13.952% volatility is expected.
Pessimistic target level: 861.01
Optimistic target level: 1 000.62

Target values for the price of one Eli Lilly and Comp. share for Sep 2024.

The weighted average target price per Eli Lilly and Comp. share in Sep 2024 is: 812.45.
In Sep, the Negative dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 11.355% volatility is expected.
Pessimistic target level: 758.58
Optimistic target level: 855.75

Target values for the price of one Eli Lilly and Comp. share for Oct 2024.

The weighted average target price per Eli Lilly and Comp. share in Oct 2024 is: 829.35.
In Oct, the Positive dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 11.685% volatility is expected.
Pessimistic target level: 806.71
Optimistic target level: 913.44

Target values for the price of one Eli Lilly and Comp. share for Nov 2024.

The weighted average target price per Eli Lilly and Comp. share in Nov 2024 is: 885.41.
In Nov, the Positive dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 12.247% volatility is expected.
Pessimistic target level: 808.29
Optimistic target level: 921.09

Target values for the price of one Eli Lilly and Comp. share for Dec 2024.

The weighted average target price per Eli Lilly and Comp. share in Dec 2024 is: 833.62.
In Dec, the Negative dynamics for Eli Lilly and Company shares will prevail with possible monthly volatility of 12.231% volatility is expected.
Pessimistic target level: 762.09
Optimistic target level: 868.29



Eli Lilly and Comp. (LLY) stock dividend

Eli Lilly and Comp. last paid dividends on 02/14/2024. The next scheduled payment will be on 03/08/2024. The amount of dividends is $4.52 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.